Rock Springs Capital Management’s Madrigal Pharmaceuticals MDGL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$89.5M Buy
170,999
+31,381
+22% +$15M 5.28% 3
2025
Q4
$81.3M Buy
139,618
+1,872
+1% +$956K 4.17% 5
2025
Q3
$63.2M Sell
137,746
-2,550
-2% -$951K 3.69% 4
2025
Q2
$42.5M Sell
140,296
-26,402
-16% -$7.87M 2.65% 9
2025
Q1
$55.2M Sell
166,698
-98,514
-37% -$32.4M 3.16% 4
2024
Q4
$81.8M Buy
265,212
+2,150
+0.8% +$605K 3.12% 8
2024
Q3
$55.8M Buy
263,062
+17,563
+7% +$4.49M 1.82% 15
2024
Q2
$68.8M Sell
245,499
-40,432
-14% -$9.62M 2.08% 10
2024
Q1
$76.4M Buy
285,931
+87,762
+44% +$20.7M 1.94% 16
2023
Q4
$45.9M Buy
198,169
+1,800
+0.9% +$315K 1.13% 30
2023
Q3
$28.7M Sell
196,369
-2,849
-1% -$536K 0.77% 44
2023
Q2
$46M Sell
199,218
-148,903
-43% -$40.3M 1.09% 31
2023
Q1
$84.3M Hold
348,121
2.01% 14
2022
Q4
$101M Buy
348,121
+30,636
+10% +$3M 2.43% 11
2022
Q3
$20.6M Hold
317,485
0.53% 54
2022
Q2
$22.7M Buy
317,485
+43,985
+16% +$3.23M 0.66% 45
2022
Q1
$26.8M Buy
273,500
+4,100
+2% +$346K 0.68% 48
2021
Q4
$22.8M Buy
269,400
+6,900
+3% +$567K 0.53% 60
2021
Q3
$20.9M Hold
262,500
0.44% 71
2021
Q2
$25.6M Buy
262,500
+4,000
+2% +$474K 0.51% 62
2021
Q1
$30.2M Buy
258,500
+1,732
+0.7% +$202K 0.66% 51
2020
Q4
$28.5M Buy
256,768
+2,500
+1% +$306K 0.61% 56
2020
Q3
$30.2M Hold
254,268
0.77% 43
2020
Q2
$28.8M Buy
254,268
+4,268
+2% +$420K 0.79% 50
2020
Q1
$16.7M Sell
250,000
-200
-0.1% -$16.7K 0.69% 52
2019
Q4
$22.8M Sell
250,200
-22,200
-8% -$2.15M 0.72% 54
2019
Q3
$23.5M Buy
272,400
+15,500
+6% +$1.45M 0.94% 38
2019
Q2
$26.9M Buy
256,900
+1,650
+0.6% +$177K 0.98% 35
2019
Q1
$32M Buy
255,250
+14,250
+6% +$1.77M 1.24% 22
2018
Q4
$27.2M Sell
241,000
-101,000
-30% -$15.6M 1.28% 24
2018
Q3
$73.2M Sell
342,000
-300
-0.1% -$75.3K 2.65% 6
2018
Q2
$95.7M Buy
342,300
+16,800
+5% +$2.95M 3.69% 2
2018
Q1
$38M Sell
325,500
-16,500
-5% -$2.04M 1.63% 13
2017
Q4
$31.4M Buy
342,000
+67,000
+24% +$3.83M 1.43% 19
2017
Q3
$12.4M Sell
275,000
-265,000
-49% -$4.96M 0.57% 56
2017
Q2
$8.78M Buy
540,000
+315,000
+140% +$4.92M 0.45% 67
2017
Q1
$3.46M Buy
225,000
+50,109
+29% +$788K 0.2% 105
2016
Q4
$2.61M Buy
174,891
+111,891
+178% +$1.8M 0.17% 105
2016
Q3
$799K Buy
+63,000
New +$610K 0.05% 133

Other funds holding MDGL